| Literature DB >> 23101463 |
Martijn D de Kruif1, Eric C M van Gorp, Elisabeth H Bel, Danielle M Gerlag, Peter W Kunst.
Abstract
Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23101463
Source DB: PubMed Journal: Clin Exp Rheumatol ISSN： 0392-856X Impact factor: 4.473